飞利浦专注于成功执行其三年计划，以在具有挑战性的宏观环境中推动运营改善并创造可持续影响的价值。 飞利浦对2025年的预期如下： • 可比销售额增长1%-3%，其中包括中国市场中个位数的中高段下降。 • 调整后的EBITA利润率将提高30-80个基点，达到11.8%-12.3%。 • 在支付与美国医疗监控和人身伤害和解相关的11亿美元现金支出之前，自由现金流将在14亿至16亿欧元的下限。扣除这笔现金支出后，自由现金流将为4亿至6亿欧元。

以上内容来自Benzinga Earnings专栏，原文如下：

Philips remains focused on successfully executing its three-year plan to drive operational improvements and create value with sustainable impact, within a challenging macro environment. 

For 2025, Philips expects: 

• 1%-3% comparable sales growth, including a mid- to high-single-digit decline in China

 • Adjusted EBITA margin increasing 30-80 bps to 11.8%-12.3% 

• Free cash flow before payment of the USD 1.1 billion cash-out relating to the US medical monitoring and personal injury settlements will be at the lower end of the range of EUR 1.4 billion to EUR 1.6 billion. Net of this cash-out, free cash flow will be EUR 0.4 billion to EUR 0.6 billion.